NSE seeks clarification on $12B Organon deal news report

SUNPHARMA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-3.5%Reaction day

₹1715.00

prior close

₹1640.00

announcement price

In-mkt

timing

Nifty 100market · index membership as recorded later (tracked since Jun 2026)+1.3%-4.8% vs market

Pharmaceuticals peers, median of 161sector+1.6%-5.1% vs sector

On the reaction day the stock moved 4.8 pts less than Nifty 100 and 5.1 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.1

10m

-0.5

15m

-0.2

30m

-0.2

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-3.5+1.3-4.8+1.6-5.1

Next day

-3.6+0.5-4.0+1.0-4.6

-1.2+2.2-3.4+2.9-4.1

-1.2+2.3-3.4+3.0-4.2

-2.3+3.1-5.4+4.1-6.4

-2.9+3.1-6.0+3.4-6.3

-2.7+3.4-6.1+3.7-6.4

15d

+6.0+2.1+3.9+6.0-0.0

+9.3+1.2+8.1+8.6+0.7

+4.2-1.2+5.4+10.6-6.4

+12.7+3.1+9.6+16.0-3.2

UpDownMarket · Nifty 100Sector · Pharmaceuticals peers, median of 161Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

NSE has asked Sun Pharma to clarify a recent news report titled 'Sun Pharma slips nearly 4% after $12 billion Organon deal enters final stage.' The company's response is awaited. No details on the deal or clarification have been provided yet.

Likely market impact

Awaiting company's response; near-term stock volatility possible as deal clarity emerges.